Disclosures for "Assessing Experiences with Trofinetide for Rett Syndrome: Interviews with Caregivers of Patients in Open-label Studies"
-
Dr. Bishop has received personal compensation for serving as an employee of Acadia Pharmaceuticals. Dr. Bishop has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for DTx Pharma.
-
-
Dr. Olayinka-Amao has received personal compensation for serving as an employee of RTI.
-
Ms. Martin has received personal compensation for serving as an employee of RTI-HS. Ms. Martin has stock in Pfizer.
-
Dr. Doshi has received personal compensation for serving as an employee of Acadia Pharmaceuticals.
-
Dr. Youakim has received personal compensation for serving as an employee of Acadia Pharmaceuticals. Dr. Youakim has stock in Acadia Pharmaceuticals.